Dezhan HealthCare Co Ltd (000813) - Total Liabilities
Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has total liabilities worth CN¥271.65 Million CNY (≈ $39.75 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dezhan HealthCare Co Ltd (000813) long-term investment share to see how much of total assets are deployed in long-term investments.
Dezhan HealthCare Co Ltd - Total Liabilities Trend (1995–2025)
This chart illustrates how Dezhan HealthCare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Dezhan HealthCare Co Ltd's balance sheet.
Dezhan HealthCare Co Ltd Competitors by Total Liabilities
The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lihuayi Weiyuan Chemical Co Ltd
SHG:600955
|
China | CN¥3.55 Billion |
|
Nobia AB
ST:NOBI
|
Sweden | Skr8.09 Billion |
|
Tianjin Capital Environmental Protection Group Co Ltd
SHG:600874
|
China | CN¥14.34 Billion |
|
Monex S.A.B. de C.V
MX:MONEXB
|
Mexico | MX$190.09 Billion |
|
Zhejiang Southeast Space Frame Co Ltd
SHE:002135
|
China | CN¥11.27 Billion |
|
Vivenio Residencial SOCIMI S.A.
MC:YVIV
|
Spain | €516.27 Million |
|
Wonders Information
SHE:300168
|
China | CN¥4.45 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Dezhan HealthCare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Dezhan HealthCare Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 16.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dezhan HealthCare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dezhan HealthCare Co Ltd (1995–2025)
The table below shows the annual total liabilities of Dezhan HealthCare Co Ltd from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥299.50 Million ≈ $43.83 Million |
+93.37% |
| 2024-12-31 | CN¥154.88 Million ≈ $22.66 Million |
+12.93% |
| 2023-12-31 | CN¥137.15 Million ≈ $20.07 Million |
-64.87% |
| 2022-12-31 | CN¥390.38 Million ≈ $57.13 Million |
+26.73% |
| 2021-12-31 | CN¥308.05 Million ≈ $45.08 Million |
-30.99% |
| 2020-12-31 | CN¥446.37 Million ≈ $65.32 Million |
+41.19% |
| 2019-12-31 | CN¥316.15 Million ≈ $46.26 Million |
-50.61% |
| 2018-12-31 | CN¥640.15 Million ≈ $93.67 Million |
+7.85% |
| 2017-12-31 | CN¥593.57 Million ≈ $86.86 Million |
+238.46% |
| 2016-12-31 | CN¥175.37 Million ≈ $25.66 Million |
-70.74% |
| 2015-12-31 | CN¥599.40 Million ≈ $87.71 Million |
-11.82% |
| 2014-12-31 | CN¥679.75 Million ≈ $99.47 Million |
+38.59% |
| 2013-12-31 | CN¥490.48 Million ≈ $71.77 Million |
+173.19% |
| 2012-12-31 | CN¥179.54 Million ≈ $26.27 Million |
-25.16% |
| 2011-12-31 | CN¥239.89 Million ≈ $35.10 Million |
+12.07% |
| 2010-12-31 | CN¥214.05 Million ≈ $31.32 Million |
+130.97% |
| 2009-12-31 | CN¥92.67 Million ≈ $13.56 Million |
+46.88% |
| 2008-12-31 | CN¥63.09 Million ≈ $9.23 Million |
-47.81% |
| 2007-12-31 | CN¥120.89 Million ≈ $17.69 Million |
-4.91% |
| 2006-12-31 | CN¥127.13 Million ≈ $18.60 Million |
-52.93% |
| 2005-12-31 | CN¥270.09 Million ≈ $39.52 Million |
-37.43% |
| 2004-12-31 | CN¥431.68 Million ≈ $63.17 Million |
-25.95% |
| 2003-12-31 | CN¥582.97 Million ≈ $85.31 Million |
+6.50% |
| 2002-12-31 | CN¥547.41 Million ≈ $80.10 Million |
-3.40% |
| 2001-12-31 | CN¥566.67 Million ≈ $82.92 Million |
-19.87% |
| 2000-12-31 | CN¥707.22 Million ≈ $103.49 Million |
+39.71% |
| 1999-12-31 | CN¥506.21 Million ≈ $74.07 Million |
-1.78% |
| 1998-12-31 | CN¥515.39 Million ≈ $75.42 Million |
-31.46% |
| 1997-12-31 | CN¥751.97 Million ≈ $110.04 Million |
+13.28% |
| 1996-12-31 | CN¥663.82 Million ≈ $97.14 Million |
+0.29% |
| 1995-12-31 | CN¥661.93 Million ≈ $96.86 Million |
-- |
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including fam… Read more